Effectiveness of the polysaccharide pneumococcal vaccine among HIV-infected persons in Brazil: a case control study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2334
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Effectiveness of the polysaccharide pneumococcal vaccine among HIV-infected persons in Brazil: a case control study ; volume:7 ; number:1 ; day:23 ; month:10 ; year:2007 ; pages:1-7 ; date:12.2007
BMC infectious diseases ; 7, Heft 1 (23.10.2007), 1-7, 12.2007
- Creator
-
Veras, Maria Amelia SM
- Contributor
-
Enanoria, Wayne TA
Castilho, Euclides A.
Reingold, Arthur L.
SpringerLink (Online service)
- DOI
-
10.1186/1471-2334-7-119
- URN
-
urn:nbn:de:1111-2016030250073
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:26 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Veras, Maria Amelia SM
- Enanoria, Wayne TA
- Castilho, Euclides A.
- Reingold, Arthur L.
- SpringerLink (Online service)
Other Objects (12)
Long-Term Serological Response to 13-Valent Pneumococcal Conjugate Vaccine Versus 23-Valent Polysaccharide Vaccine in HIV-Infected Adults
High Streptococcus pneumoniae colonization prevalence among HIV-infected Kenyan parents in the year before pneumococcal conjugate vaccine introduction
Effect of 23-valent pneumococcal polysaccharide vaccine on medical expenses in Japan
The effect of age on the response to the pneumococcal polysaccharide vaccine
Cost-effectiveness of 20-valent pneumococcal conjugate vaccine compared with 23-valent pneumococcal polysaccharide vaccine among adults in a Norwegian setting
Effectiveness of the 23-valent polysaccharide pneumococcal vaccine against invasive pneumococcal disease in people 60 years or older
Emerging pneumococcal carriage serotypes in a high-risk population receiving universal 7-valent pneumococcal conjugate vaccine and 23-valent polysaccharide vaccine since 2001
Mortality reduction with 23-valent pneumococcal polysaccharide vaccine: a systematic review and meta-analysis
Effectiveness of the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) against Pneumococcal Disease in the Elderly: Systematic Review and Meta-Analysis
Long-term protection of hepatitis B vaccine in HIV-infected patients
Adverse events of inactivated COVID-19 vaccine in HIV-infected adults
Adverse events of inactivated COVID-19 vaccine in HIV-infected adults
Long-Term Serological Response to 13-Valent Pneumococcal Conjugate Vaccine Versus 23-Valent Polysaccharide Vaccine in HIV-Infected Adults
High Streptococcus pneumoniae colonization prevalence among HIV-infected Kenyan parents in the year before pneumococcal conjugate vaccine introduction
Effect of 23-valent pneumococcal polysaccharide vaccine on medical expenses in Japan
The effect of age on the response to the pneumococcal polysaccharide vaccine
Cost-effectiveness of 20-valent pneumococcal conjugate vaccine compared with 23-valent pneumococcal polysaccharide vaccine among adults in a Norwegian setting
Effectiveness of the 23-valent polysaccharide pneumococcal vaccine against invasive pneumococcal disease in people 60 years or older
Emerging pneumococcal carriage serotypes in a high-risk population receiving universal 7-valent pneumococcal conjugate vaccine and 23-valent polysaccharide vaccine since 2001
Mortality reduction with 23-valent pneumococcal polysaccharide vaccine: a systematic review and meta-analysis
Effectiveness of the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) against Pneumococcal Disease in the Elderly: Systematic Review and Meta-Analysis
Long-term protection of hepatitis B vaccine in HIV-infected patients
Adverse events of inactivated COVID-19 vaccine in HIV-infected adults
Adverse events of inactivated COVID-19 vaccine in HIV-infected adults
Long-Term Serological Response to 13-Valent Pneumococcal Conjugate Vaccine Versus 23-Valent Polysaccharide Vaccine in HIV-Infected Adults
High Streptococcus pneumoniae colonization prevalence among HIV-infected Kenyan parents in the year before pneumococcal conjugate vaccine introduction
Effect of 23-valent pneumococcal polysaccharide vaccine on medical expenses in Japan
The effect of age on the response to the pneumococcal polysaccharide vaccine
Cost-effectiveness of 20-valent pneumococcal conjugate vaccine compared with 23-valent pneumococcal polysaccharide vaccine among adults in a Norwegian setting
Effectiveness of the 23-valent polysaccharide pneumococcal vaccine against invasive pneumococcal disease in people 60 years or older
Emerging pneumococcal carriage serotypes in a high-risk population receiving universal 7-valent pneumococcal conjugate vaccine and 23-valent polysaccharide vaccine since 2001
Mortality reduction with 23-valent pneumococcal polysaccharide vaccine: a systematic review and meta-analysis
Effectiveness of the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) against Pneumococcal Disease in the Elderly: Systematic Review and Meta-Analysis
Long-term protection of hepatitis B vaccine in HIV-infected patients
Adverse events of inactivated COVID-19 vaccine in HIV-infected adults